Tari Leslie

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$9,700.00
Insider Sells Quantity
7
Insider Sells Sum
$81,922.71

Insider Activity of Tari Leslie

According to the SEC Form 4 filings, Tari Leslie, being in a position of

  1. CHIEF SCIENTIFIC OFFICER at Cidara Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21938 shares for $24,665,
    over all time since 2022-01-05, has bought 10000 shares for $9,700, and sold 79194 shares for $81,923.

The largest purchase of all time was on 2023-08-14 and amounted to 10000 shares of Cidara Therapeutics, Inc. for $9,700.

The largest sale of all time was on 2023-09-11 and amounted to 18469 shares of Cidara Therapeutics, Inc. for $17,509.

Biography of Tari Leslie

No biography is available at this moment.

2024-09-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
909
0.0126%
$11.64$10,580+2.6%
2024-03-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
21,029
0.0235%
$0.67$14,085-4.43%
2023-09-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
18,469
0.0202%
$0.95$17,509-26.2%
2023-08-14PurchaseCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
10,000
0.0118%
$0.97$9,700-20.54%
2023-03-13SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
7,562
0.0085%
$1.53$11,570-45.66%
2023-01-12SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
11,814
0.015%
$1.20$14,177-13.33%
2022-09-12SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
18,159
0.026%
$0.68$12,437+51.03%
2022-01-05SaleCidara Therapeutics, Inc.
CDTX
Chief Scientific Officer
1,252
0.002%
$1.25$1,565-41.37%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.